Literature DB >> 17308287

Lowering the bleeding risk in intra-arterial thrombolysis without losing efficiency by excluding adjunctive heparin?

Paul Trouillas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308287      PMCID: PMC2117659          DOI: 10.1136/jnnp.2006.101493

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

Review 1.  Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke.

Authors:  Paul Trouillas; Rüdiger von Kummer
Journal:  Stroke       Date:  2006-01-05       Impact factor: 7.914

2.  Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study.

Authors:  Bernd Eckert; Christoph Koch; Götz Thomalla; Thomas Kucinski; Ulrich Grzyska; Joachim Roether; Karsten Alfke; Olav Jansen; Herrmann Zeumer
Journal:  Stroke       Date:  2005-05-12       Impact factor: 7.914

3.  Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

Authors:  C B Granger; R Becker; R P Tracy; R M Califf; E J Topol; K S Pieper; A M Ross; S Roth; C Lambrew; E G Bovill
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

4.  Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.

Authors:  C S Kase; A J Furlan; L R Wechsler; R T Higashida; H A Rowley; R G Hart; G F Molinari; L S Frederick; H C Roberts; J M Gebel; C A Sila; G A Schulz; R S Roberts; M Gent
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.